{"id":"W4401027392","doi":"10.1183/13993003.00512-2024","title":"Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; University of Alberta; University of Saskatchewan; University of Calgary; Vancouver General Hospital; University of British Columbia; McMaster University","funders":"Saskatchewan Health Research Foundation; Canadian Institutes of Health Research; Covis Pharma; Université Laval; Regeneron Pharmaceuticals; Genentech; Grifols; AstraZeneca Canada; Teva Pharmaceutical Industries; Amgen; Canadian Thoracic Society; Sanofi; AstraZeneca; Pfizer; GlaxoSmithKline","keywords":"Medicine; Benralizumab; Placebo; Double blind; Asthma; Allergic asthma; Internal medicine; Alternative medicine; Mepolizumab; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002479644,0.001555886,0.005342686,0.0006139053,0.0005938604,0.001498502,0.001289166,0.00398022,0.01102581],"category_scores_gemma":[0.002962374,0.0009184539,0.002611153,0.0005911182,0.001389806,0.001256947,0.0005643807,0.00226832,0.001287413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008416104,"about_ca_system_score_gemma":0.00126303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001315584,"about_ca_topic_score_gemma":0.002351253,"domain_scores_codex":[0.9986346,0.0007560684,0.0001245873,0.0002360228,0.0001032255,0.0001454222],"domain_scores_gemma":[0.9990693,0.0003247893,0.0002719188,0.00005848407,0.00008338249,0.0001921799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830849,0.001624461,0.0002268649,0.003942927,0.001329045,0.00004325344,0.00003000888,0.00009609601,0.001083959,0.00008390376,0.0006946494,0.007760037],"study_design_scores_gemma":[0.9933749,0.005437693,0.0003165618,0.00009806018,0.0003208929,0.00001358754,0.000007742369,0.00005728507,0.00003983073,0.0000380024,0.0002904906,0.000004946339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8604504,0.1051591,0.001796767,0.00408164,0.005919967,0.01439069,0.002902575,0.0003890331,0.004909929],"genre_scores_gemma":[0.9251332,0.03477111,0.003459953,0.004249788,0.002413,0.0214096,0.001495181,0.00004803469,0.007020209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01102581,"threshold_uncertainty_score":0.03688502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04276347451274549,"score_gpt":0.3198430396320378,"score_spread":0.2770795651192923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}